p63 expression correlates with sensitivity to the Eg5 inhibitor AZD4877 in bladder cancer cells

Progress on Kinesin Spindle Protein Inhibitors as Anti-Cancer Agents

(2013) Yingjie Zhang et al.   Anti-Cancer Agents in Medicinal Chemistry

p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers

(2012) Woonyoung Choi et al.   PLoS One

Distinct Expression Profiles of p63 Variants during Urothelial Development and Bladder Cancer Progression

(2011) Orit Karni-Schmidt et al.   AMERICAN JOURNAL OF PATHOLOGY

Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63

(2011) Shu-Er Chow et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

(2011) Steven Christopher Smith et al.   LANCET ONCOLOGY

Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

(2011) Yaoting Gui et al.   NATURE GENETICS

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells

(2010) Adam R. Metwalli et al.   CANCER BIOLOGY & THERAPY

The COXEN Principle: Translating Signatures of In vitro Chemosensitivity into Tools for Clinical Outcome Prediction and Drug Discovery in Cancer

(2010) S. C. Smith et al.   CANCER RESEARCH

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

(2010) Lucie C. Kompier et al.   PLoS One

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer

(2009) David J. McConkey et al.   CANCER AND METASTASIS REVIEWS

Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

(2009) T. Arumugam et al.   CANCER RESEARCH

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

A  -catenin/TCF-coordinated chromatin loop at MYC integrates 5' and 3' Wnt responsive enhancers

(2009) G. S. Yochum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cell Type Variation in Responses to Antimitotic Drugs that Target Microtubules and Kinesin-5

(2008) J. Shi et al.   CANCER RESEARCH

A Genome-Wide Screen for  -Catenin Binding Sites Identifies a Downstream Enhancer Element That Controls c-Myc Gene Expression

(2008) G. S. Yochum et al.   MOLECULAR AND CELLULAR BIOLOGY

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

(2008) Philip A. Gregory et al.   NATURE CELL BIOLOGY